Inflammatory Diseases of the Middle Ear Clinical Presentation

  • Author: Nasir Aziz, MD, MA; Chief Editor: Arlen D Meyers, MD, MBA   more...
 
Updated: Feb 1, 2010
 

History

The earliest clinical manifestation of acute suppurative otitis media is a sense of fullness in the ear with some conductive hearing loss. An earache may be present but is not severe.

In the exudative stage, the middle ear fills with an exudate, which is under pressure. Marked otalgia and fever are also present. In smaller children, anorexia, vomiting, and diarrhea may occur. Conductive hearing loss is noticeable. If the infection progresses, the tympanic membrane may perforate, initially producing hemorrhagic discharge and then mucopurulent discharge. The otalgia usually reduces after perforation.

The 2 classic symptoms of chronic suppurative otitis media (CSOM; mucosal disease) include otorrhea and hearing loss, which can affect one or both ears. The discharge varies in character, from serous or mucoid to frankly purulent, and the discharge may be intermittent or continuous. Blood-stained discharge is found in association with florid granulation tissue and aural polyps, and it is a common indicator of underlying cholesteatoma.

The predominant form of hearing loss associated with chronic middle ear disease is conductive in nature. More recently, the occurrence of sensorineural hearing loss in the ears with chronic discharge has been recognized. This hearing loss, which mainly involves high frequencies, is thought to result from the passage of bacterial toxins across the round window membrane to the cochlea.

The main symptom of CSOM with cholesteatoma is purulent otorrhea, with or without associated conductive hearing loss, similar to that of mucosal disease alone. Signs found during physical examination coupled with radiologic imaging findings are critical for the diagnosis of cholesteatoma because history symptoms are largely unreliable for determining the presence of cholesteatoma.

Next

Physical

Otoscopic examination in patients with AOM reveals a hyperemic, opaque, bulging tympanic membrane. Pneumatic otoscopy demonstrates reduced mobility. Mucopurulent otorrhea is a reliable sign.

When the diagnosis of otitis media with effusion (OME) is questionable, tympanometry can be beneficial in the examination of infants older than 4 months. Alternatively, acoustic reflectometry with spectral gradient analysis may also be used because it costs less and does not require an airtight seal in the ear canal.

Examination with an operating microscope and adequate suction equipment is required for CSOM diagnosis. In young children, a short-acting, general anesthetic is sometimes required, especially when suction is needed.

In ears without cholesteatoma, the perforation is usually of the central type. Perforations vary in size, and the activity of the disease relates to the degree of discharge. The discharge may be mucoid or purulent. Microbiological swabs should be obtained to identify aerobic and anaerobic pathogens. Pulsatile purulent discharge occurs in heavily infected cases with capillary engorgement of the middle ear mucosa.

If the size of the perforation permits, various middle ear structures can be visualized. The middle ear mucosa is either normal or edematous, and aural polyps may be present, arising from the middle ear mucosa or the margins of the perforation. The most common ossicular abnormalities include disruption of the incudostapedial joint, necrosis of the incus long process, and medial retraction and shortening of the malleus handle. Other features include secondary otitis externa in ears with profuse discharge and scars in patients who have previously undergone otologic surgery.

The hearing loss should be assessed clinically using Rinne and Weber tuning fork tests.

In patients with CSOM with cholesteatoma, the site and the extent of the tympanic membrane defect and the presence and the extent of squamous epithelium and keratin debris should be noted. The involvement of the ossicular chain and the presence of inflammatory polyps, granulation tissue, or osteitis should also be noted.

Rigid lens otoscopy is particularly useful in assessing the extent of cholesteatoma.

The use of angled endoscopes permits examination of the facial recess and the sinus tympani, which is often involved in pars tensa cholesteatoma.

Postnasal space masses can block the orifices of the eustachian tube and cause otitis media. Therefore, an examination of an adult with unilateral otitis media must include a postnasal evaluation with flexible fiberoptic nasopharyngoscopy.

Previous
Next

Causes

  • Acute otitis media (AOM) prevalence varies by season, with an increased incidence in the colder months.
  • Daycare is a major risk factor in the incidence of middle ear infections. Upper airway hygiene in children who attend daycare is poor, and coughing, sneezing, and nasal dripping contaminate the environment with bacteria and viruses.
  • Anatomical variants, such as of the overt and submucous cleft palate, may cause recurrent episodes, often with subsequent complications.
  • Immunologic deficiencies and functional changes (eg, barotrauma, patulous eustachian tube) have an important influence on the incidence of middle ear infections.
  • Adenoid hypertrophy may be an important factor in the etiology of recurrent attacks, possibly because of its close relationship to the eustachian tube.
  • Passive smoking has been shown to be associated with the occurrence of otitis media, especially in preschool-aged children whose parents smoke.
  • Allergic rhinitis in children has been shown to be associated with higher prevalence of otitis media with effusion (OME). Inflammatory obstruction of the nasopharynx may lead to inflammatory swelling of the eustachian tube with resultant obstruction. This facilitates a reflux of bacteria-laden allergic nasopharyngeal secretions that can then enter the middle ear cavity to cause repeated bouts of otitis media.
  • Gastroesophageal reflux disease has also been recently implicated in the pathogenesis of OME. A recent study revealed higher concentrations (up to 1000-fold greater than serum levels) of pepsin/pepsinogen in children with OME. Although direct mechanistic causation has not been shown, the authors concluded that reflux of gastric juice into the middle ear may be the primary factor in the initiation of OME in children.
  • Several studies have attempted to determine a genetic link to recurrent otitis media. A recent study examined the frequency of otitis media in infants hospitalized with respiratory syncytial virus (RSV) infection and found that a certain interferon gamma (IFN-γ) polymorphism may represent one member of a family of genes that contributes to the measured heritability of otitis media. Rates of otitis media are significantly concordant in monozygotic twins.
Previous
 
 
Contributor Information and Disclosures
Author

Nasir Aziz, MD, MA  Resident Physician, Riverside Regional Medical Center

Disclosure: Nothing to disclose.

Coauthor(s)

Diego A Preciado, MD, PhD, FAAP  Assistant Professor, Department of Otolaryngology, Division of Pediatric Otolaryngology, George Washington University School of Medicine, Children's National Medical Center

Diego A Preciado, MD, PhD, FAAP is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American Society of Pediatric Otolaryngology, and Association for Research in Otolaryngology

Disclosure: Nothing to disclose.

Specialty Editor Board

John C Li, MD  Private Practice in Otology and Neurotology; Medical Director, Balance Center

John C Li, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Medical Association, American Neurotology Society, American Tinnitus Association, Florida Medical Association, and North American Skull Base Society

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Gerard J Gianoli, MD  Clinical Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Tulane University School of Medicine; Vice President, The Ear and Balance Institute; Chief Executive Officer, Ponchartrain Surgery Center

Gerard J Gianoli, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, American Neurotology Society, American Otological Society, Society of University Otolaryngologists-Head and Neck Surgeons, and Triological Society

Disclosure: Vesticon, Inc. None Board membership

Christopher L Slack, MD  Private Practice in Otolaryngology and Facial Plastic Surgery, Associated Coastal ENT; Medical Director, Treasure Coast Sleep Disorders

Christopher L Slack, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Medical Association

Disclosure: Nothing to disclose.

Chief Editor

Arlen D Meyers, MD, MBA  Professor, Department of Otolaryngology-Head and Neck Surgery, University of Colorado School of Medicine

Arlen D Meyers, MD, MBA is a member of the following medical societies: American Academy of Facial Plastic and Reconstructive Surgery, American Academy of Otolaryngology-Head and Neck Surgery, and American Head and Neck Society

Disclosure: Covidien Corp Consulting fee Consulting; US Tobacco Corporation Unrestricted gift Unknown; Axis Three Corporation Ownership interest Consulting; Omni Biosciences Ownership interest Consulting; Sentegra Ownership interest Board membership; Syndicom Ownership interest Consulting; Oxlo Consulting; Medvoy Ownership interest Management position; Cerescan Imaging Honoraria Consulting; GYRUS ACMI Honoraria Consulting

Additional Contributors

The authors and editors of eMedicine gratefully acknowledge the contributions of previous author Sanjeev Silva, MBBS, MRCS, DLO, to the development and writing of this article.

References
  1. Iino Y, Nagamine H, Kakizaki K, et al. Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma. Ann Allergy Asthma Immunol. Dec 2006;97(6):761-6. [Medline].

  2. Coughlin L. AHRQ data on antibiotic use in children with otitis media. American Family Physician. June 2005.

  3. Browning GC. Medical management of chronic mucosal otitis media. Clin Otolaryngol Allied Sci. Jun 1984;9(3):141-4. [Medline].

  4. Dubey SP, Larawin V, Molumi CP. Intracranial spread of chronic middle ear suppuration. Am J Otolaryngol. Mar 31 2009;[Medline].

  5. Balbani AP, Montovani JC. [Impact of otitis media on language acquisition in children]. J Pediatr (Rio J). Sep-Oct 2003;79(5):391-6. [Medline].

  6. Aberg B, Westin T, Tjellstrom A, Edstrom S. Clinical characteristics of cholesteatoma. Am J Otolaryngol. Sep-Oct 1991;12(5):254-8. [Medline].

  7. Balbani AP, Montovani JC. [Impact of otitis media on language acquisition in children]. J Pediatr (Rio J). Sep-Oct 2003;79(5):391-6. [Medline].

  8. Bluestone CD. Clinical course, complications and sequelae of acute otitis media. Pediatr Infect Dis J. May 2000;19(5 Suppl):S37-46. [Medline].

  9. Bluestone CD. Pathogenesis of otitis media: role of eustachian tube. Pediatr Infect Dis J. Apr 1996;15(4):281-91. [Medline].

  10. Casselbrant ML, Mandel EM, Rockette HE, Kurs-Lasky M, Fall PA, Bluestone CD, et al. The genetic component of middle ear disease in the first 5 years of life. Arch Otolaryngol Head Neck Surg. Mar 2004;130(3):273-8. [Medline].

  11. DeSouza CE, Menezes CO, DeSouza RA, Ogale SB, Morris M, Desai AP. Profile of congenital cholesteatomas of the petrous apex. J Postgrad Med. Apr 1989;35(2):93-7. [Medline].

  12. Dobben GD, Raofi B, Mafee MF, Kamel A, Mercurio S. Otogenic intracranial inflammations: role of magnetic resonance imaging. Top Magn Reson Imaging. Apr 2000;11(2):76-86. [Medline].

  13. Fireman P. Otitis media and eustachian tube dysfunction: connection to allergic rhinitis. J Allergy Clin Immunol. Feb 1997;99(2):S787-97. [Medline].

  14. Freid VM, Makuc DM, Rooks RN. Ambulatory health care visits by children: principal diagnosis and place of visit. Vital Health Stat 13. May 1998;(137):1-23. [Medline].

  15. Giles M, Asher I. Prevalence and natural history of otitis media with perforation in Maori school children. J Laryngol Otol. Apr 1991;105(4):257-60. [Medline].

  16. Harker LA, Koontz FP. The bacteriology of cholesteatoma. Cholesteatoma: First International Conference. 1977;287-92.

  17. Heikkinen T, Chonmaitree T. Importance of respiratory viruses in acute otitis media. Clin Microbiol Rev. Apr 2003;16(2):230-41. [Medline].

  18. Iino Y, Kakizaki K, Katano H, Saigusa H, Kanegasaki S. Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media. Clin Exp Allergy. Oct 2005;35(10):1370-6. [Medline].

  19. Kangsanarak J, Fooanant S, Ruckphaopunt K, Navacharoen N, Teotrakul S. Extracranial and intracranial complications of suppurative otitis media. Report of 102 cases. J Laryngol Otol. Nov 1993;107(11):999-1004. [Medline].

  20. Katherine L. O'Brien and Mathuram Santosham Potential Impact of Conjugate Pneumococcal Vaccines on Pediatric Pneumococcal Diseases. 159. Am J Epidemiol; 2004:634-644.

  21. Mafee MF. MRI and CT in the evaluation of acquired and congenital cholesteatomas of the temporal bone. J Otolaryngol. Aug 1993;22(4):239-48. [Medline].

  22. Merifield DO, Parker NJ, Nicholson NC. Therapeutic management of chronic suppurative otitis media with otic drops. Otolaryngol Head Neck Surg. Jul 1993;109(1):77-82. [Medline].

  23. Miceli Sopo S, Zorzi G, Calvani M Jr. Should we screen every child with otitis media with effusion for allergic rhinitis?. Arch Dis Child. Mar 2004;89(3):287-8. [Medline].

  24. Michaels L. An epidermoid formation in the developing middle ear: possible source of cholesteatoma. J Otolaryngol. Jun 1986;15(3):169-74. [Medline].

  25. Patel JA, Nguyen DT, Revai K, Chonmaitree T. Role of respiratory syncytial virus in acute otitis media: implications for vaccine development. Vaccine. Feb 19 2007;25(9):1683-9. Epub 2006 Nov 9. [Medline].

  26. Pichichero ME, Pichichero CL. Persistent acute otitis media: I. Causative pathogens. Pediatr Infect Dis J. Mar 1995;14(3):178-83. [Medline].

  27. Poelmans J, Tack J. Extraoesophageal manifestations of gastro-oesophageal reflux. Gut. Oct 2005;54(10):1492-9. [Medline].

  28. Spector ND, Kelly SF. Medical home, obesity, acute otitis media, and otitis media with effusion. Curr Opin Pediatr. Dec 2004;16(6):706-22. [Medline].

  29. Stangerup SE, Tos M. Epidemiology of acute suppurative otitis media. Am J Otolaryngol. Jan-Feb 1986;7(1):47-54. [Medline].

Previous
Next
 
Middle ear anatomy.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.